GLP-1 Weight-Loss Drugs Quietly Trim Cravings for Alcohol

Weight‑loss meds like Wegovy, Ozempic, and Mounjaro (GLP-1 agonists) may also dampen alcohol cravings and consumption for some users. Reports and early studies show people drinking less—some with strong nausea or fullness after alcohol—while others notice little change. While these effects could aid weight loss and alter drinking habits, safety concerns, potential off-label use for alcohol use disorder, and the need for larger, longer studies mean regulators haven’t endorsed using these drugs for addiction treatment beyond obesity/diabetes populations.